EGFR and nasopharyngeal carcinoma: In this study, based on the clinical data of EGFR-positive NPC patients, the equation was constructed: Y = 0.3199 + 2.494X1 + − 0.7547 × 2 (Y = efficacy, X1 = targeted drug therapy, X2 = T stage).